Acer Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Acer Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2023.
  • Acer Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $200K, a 33.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $200K -$100K -33.3% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $200K -$100K -33.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $200K -$100K -33.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $200K -$200K -50% Dec 31, 2022 10-K 2023-03-27
Q3 2022 $300K +$100K +50% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $300K +$100K +50% Jun 30, 2022 10-Q/A 2022-11-14
Q1 2022 $300K $0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $400K $0 0% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $200K -$200K -50% Sep 30, 2021 10-Q 2021-11-19
Q2 2021 $200K -$300K -60% Jun 30, 2021 10-Q/A 2021-11-19
Q1 2021 $300K -$200K -40% Mar 31, 2021 10-Q/A 2021-11-19
Q4 2020 $400K -$200K -33.3% Dec 31, 2020 10-K 2021-03-01
Q3 2020 $400K -$100K -20% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $500K +$300K +150% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $500K +$100K +25% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $600K +$200K +50% Dec 31, 2019 10-K 2020-03-18
Q3 2019 $500K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $200K Jun 30, 2019 10-Q 2019-11-13
Q1 2019 $400K Mar 31, 2019 10-K 2021-03-01
Q4 2018 $400K Jan 1, 2019 10-K 2020-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.